NCT02318810View on ClinicalTrials.gov

Influence of the Neuromuscular Blockade on Mask Ventilation

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Complication of Ventilation TherapyObservation of Neuromuscular Block
Interventions
DRUG

Rocuronium 0.3 mg/kg

Patients receive rocuronium 0.3 mg/kg

DRUG

Rocuronium 0.6 mg/kg

Patients receive rocuronium 0.6 mg/kg

DRUG

Rocuronium 0.9 mg/kg

Patients receive rocuronium 0.9 mg/kg

DRUG

Placebo

Patients receive saline

Trial Locations (1)

18057

Department of Anesthesia and Intensive Care Medicine, University of Rostock, Rostock

All Listed Sponsors
lead

University of Rostock

OTHER

NCT02318810 - Influence of the Neuromuscular Blockade on Mask Ventilation | Biotech Hunter | Biotech Hunter